<?xml version="1.0" encoding="UTF-8"?><mods xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.3" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd" ID="id-2014-03580">
    <name type="corporate">
        <namePart>United States Government Publishing Office</namePart>
        <role>
            <roleTerm authority="marcrelator" type="text">publisher</roleTerm>
            <roleTerm authority="marcrelator" type="code">pbl</roleTerm>
        </role>
        <role>
            <roleTerm authority="marcrelator" type="text">distributor</roleTerm>
            <roleTerm authority="marcrelator" type="code">dst</roleTerm>
        </role>
    </name>
    <name type="corporate">
        <namePart>United States</namePart>
        <namePart>National Archives and Records Administration</namePart>
        <namePart>Office of the Federal Register</namePart>
        <role>
            <roleTerm authority="marcrelator" type="text">author</roleTerm>
            <roleTerm authority="marcrelator" type="code">aut</roleTerm>
        </role>
        <description>Government Organization</description>
    </name>
    <typeOfResource>text</typeOfResource>
    <genre authority="marcgt">government publication</genre>
    <language>
        <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
    </language>
    <extension>
        <collectionCode>FR</collectionCode>
        <category>Regulatory Information</category>
        <waisDatabaseName>2014_register</waisDatabaseName>
        <branch>executive</branch>
        <dateIngested>2014-02-19</dateIngested>
    </extension>
    <genre authority="marcgt">article</genre>
    <titleInfo>
        <title>Draft Guidance for Industry on Analytical Procedures and Methods Validation for Drugs and Biologics; Availability</title>
        <partName>Notices</partName>
    </titleInfo>
    <relatedItem type="otherFormat" xlink:href="https://www.govinfo.gov/content/pkg/FR-2014-02-19/html/2014-03580.htm">
        <identifier type="FDsys Unique ID">D09002ee1c7fa6a24</identifier>
    </relatedItem>
    <relatedItem type="otherFormat" xlink:href="https://www.govinfo.gov/content/pkg/FR-2014-02-19/pdf/2014-03580.pdf">
        <identifier type="FDsys Unique ID">D09002ee1c7fa6a91</identifier>
    </relatedItem>
    <name type="corporate">
        <namePart>United States</namePart>
        <namePart>Department of Health and Human Services</namePart>
        <role>
            <roleTerm authority="marcrelator" type="text">originator</roleTerm>
            <roleTerm authority="marcrelator" type="code">org</roleTerm>
        </role>
        <description>United States Government Agency or Subagency</description>
    </name>
    <name type="corporate">
        <namePart>United States</namePart>
        <namePart>Food and Drug Administration</namePart>
        <role>
            <roleTerm authority="marcrelator" type="text">originator</roleTerm>
            <roleTerm authority="marcrelator" type="code">org</roleTerm>
        </role>
        <description>United States Government Agency or Subagency</description>
    </name>
    <abstract>The Food and Drug Administration (FDA) is announcing the availability of a draft guidance for industry entitled "Analytical Procedures and Methods Validation for Drugs and Biologics." This revised draft guidance supersedes the 2000 draft guidance for industry on "Analytical Procedures and Methods Validation" and, when finalized, will also replace the 1987 FDA guidance for industry on "Submitting Samples and Analytical Data for Methods Validation." This draft guidance discusses how to submit analytical procedures and methods validation data to support the documentation of the identity, strength, quality, purity, and potency of drug substances and drug products.</abstract>
    <identifier type="FR citation">79 FR 9467</identifier>
    <identifier type="uri">https://www.govinfo.gov/app/details/FR-2014-02-19/2014-03580</identifier>
    <identifier type="FR Doc No.">2014-03580</identifier>
    <identifier type="former granule identifier">fr19fe14-40</identifier>
    <identifier type="billing code">4160-01-P</identifier>
    <identifier type="department code">Docket No. FDA-2014-D-0103</identifier>
    <location>
        <url displayLabel="Content Detail" access="object in context">https://www.govinfo.gov/app/details/FR-2014-02-19/2014-03580</url>
        <url access="raw object" displayLabel="HTML rendition">https://www.govinfo.gov/content/pkg/FR-2014-02-19/html/2014-03580.htm</url>
        <url access="raw object" displayLabel="PDF rendition">https://www.govinfo.gov/content/pkg/FR-2014-02-19/pdf/2014-03580.pdf</url>
    </location>
    <physicalDescription>
        <extent>2 p.</extent>
    </physicalDescription>
    <part type="Notices">
        <extent unit="pages">
            <start>9467</start>
            <end>9468</end>
        </extent>
    </part>
    <identifier type="preferred citation">79 FR 9467</identifier>
    <extension>
        <searchTitle>Draft Guidance for Industry on Analytical Procedures and Methods Validation for Drugs and Biologics; Availability; Federal Register Vol. 79, Issue </searchTitle>
        <granuleClass>NOTICE</granuleClass>
        <accessId>2014-03580</accessId>
        <agency order="1">DEPARTMENT OF HEALTH AND HUMAN SERVICES</agency>
        <agency order="2">Food and Drug Administration</agency>
        <departmentDoc>Docket No. FDA-2014-D-0103</departmentDoc>
        <billingCode>4160-01-P</billingCode>
        <frDocNumber>2014-03580</frDocNumber>
        <action>Notice.</action>
        <summary>The Food and Drug Administration (FDA) is announcing the availability of a draft guidance for industry entitled "Analytical Procedures and Methods Validation for Drugs and Biologics." This revised draft guidance supersedes the 2000 draft guidance for industry on "Analytical Procedures and Methods Validation" and, when finalized, will also replace the 1987 FDA guidance for industry on "Submitting Samples and Analytical Data for Methods Validation." This draft guidance discusses how to submit analytical procedures and methods validation data to support the documentation of the identity, strength, quality, purity, and potency of drug substances and drug products.</summary>
        <dates>Although you can comment on any guidance at any time (see 21 CFR 10.115(g)(5)), to ensure that the Agency considers your comment on this draft guidance before it begins work on the final version of the guidance, submit either electronic or written comments on the draft guidance by May 20, 2014.</dates>
        <contact>Lucinda Buhse, Center for Drug Evaluation and Research, Food and Drug Administration, 1114 Market St., Suite 1002, St. Louis, MO 63101, 314-539-2134; or Stephen Ripley, Center for Biologics Evaluation and Research (HFM-17), Food and Drug Administration, 1401 Rockville Pike, Suite 200N, Rockville, MD 20852- 1448, 301-827-6210.</contact>
        <tocSubject1>Draft Guidance for Industry:</tocSubject1>
        <tocDoc>Analytical Procedures and Methods Validation for Drugs and Biologics
, </tocDoc>
        <urlRef>http://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/default.htm</urlRef>
        <urlRef>http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/default.htm</urlRef>
        <urlRef>http://www.regulations.gov</urlRef>
    </extension>
    <relatedItem type="host" ID="P0b002ee1873c1a1d" xlink:href="https://www.govinfo.gov/metadata/pkg/FR-2014-02-19/mods.xml">
        <titleInfo>
            <title>Federal Register</title>
            <partNumber>Vol. 79, no. 33</partNumber>
        </titleInfo>
        <originInfo>
            <publisher>Office of the Federal Register, National Archives and Records Administration</publisher>
            <dateIssued encoding="w3cdtf">2014-02-19</dateIssued>
            <issuance>continuing</issuance>
            <frequency>daily</frequency>
        </originInfo>
        <physicalDescription>
            <note type="source content type">deposited</note>
            <digitalOrigin>born digital</digitalOrigin>
            <extent>249 p.</extent>
        </physicalDescription>
        <tableOfContents xlink:href="https://www.govinfo.gov/app/frtoc/2014-02-19">    
		  Table of Contents: 
		</tableOfContents>
        <classification authority="sudocs">AE 2.7:</classification>
        <classification authority="sudocs">GS 4.107:</classification>
        <classification authority="sudocs">AE 2.106:</classification>
        <classification authority="lcc">KF70.A2</classification>
        <identifier type="uri">https://www.govinfo.gov/app/details/FR-2014-02-19</identifier>
        <identifier type="local">P0b002ee1873c1a1d</identifier>
        <identifier type="issn">0097-6326</identifier>
        <identifier type="issn">0042-1219</identifier>
        <identifier type="issn">0364-1406</identifier>
        <identifier type="stock number">769-004-00000-9</identifier>
        <identifier type="ILS system id">000582072</identifier>
        <identifier type="former identifier">f:fr19fe14</identifier>
        <location>
            <url displayLabel="Content Detail" access="object in context">https://www.govinfo.gov/app/details/FR-2014-02-19</url>
            <url displayLabel="PDF rendition" access="raw object">https://www.govinfo.gov/content/pkg/FR-2014-02-19/pdf/FR-2014-02-19.pdf</url>
            <url displayLabel="XML rendition" access="raw object">https://www.govinfo.gov/content/pkg/FR-2014-02-19/xml/FR-2014-02-19.xml</url>
        </location>
        <accessCondition type="GPO scope determination">fdlp</accessCondition>
        <part type="issue">
            <extent unit="pages">
                <start>9379</start>
                <end>9619</end>
            </extent>
        </part>
        <recordInfo>
            <recordContentSource authority="marcorg">DGPO</recordContentSource>
            <recordCreationDate encoding="w3cdtf">2014-02-19</recordCreationDate>
            <recordChangeDate encoding="w3cdtf">2024-06-03</recordChangeDate>
            <recordIdentifier source="DGPO">FR-2014-02-19</recordIdentifier>
            <recordOrigin>machine generated</recordOrigin>
            <languageOfCataloging>
                <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
            </languageOfCataloging>
        </recordInfo>
        <extension>
            <docClass>FR</docClass>
            <accessId>FR-2014-02-19</accessId>
            <volume>79</volume>
            <issue>33</issue>
        </extension>
    </relatedItem>
</mods>
